Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Comella

Showing results (151-160 of 684) with videos related to

Pageof 69
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 21, 2010
Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's diseaseJaney Prodoehl, Mathew Spraker, Daniel Corcos, et al.
Parkinsonism & Related Disorders|March 8, 2008
Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trialDaniel Truong, Cynthia Comella, Hubert H Fernandez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, P Comella, F Rivellini, et al.
Oncology|January 26, 2002
A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patientsGiuseppe Frasci, Giuseppe D'Aiuto, Pasquale Comella, et al.
Journal of Neuroscience Methods|October 21, 2000
Combined use of the green and yellow fluorescent proteins and fluorescence-activated cell sorting to select populations of transiently transfected PC12 cellsC Espinet, X Gómez-Arbonés, J Egea, et al.
Revista Clinica Espanola|June 1, 1991
[A study of the tobacco habit in a general hospital]J Serra Batlles, A Comella, J C Casas, et al.
Therapeutics and Clinical Risk Management|May 14, 2009
Role of oxaliplatin in the treatment of colorectal cancerPasquale Comella, Rossana Casaretti, Claudia Sandomenico, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Tetrodotoxin-sensitive ciguatoxin effects on quantal release, synaptic vesicle depletion, and calcium mobilizationJ Molgo, J X Comella, T Shimahara, et al.
ACS Omega|October 13, 2025
Pressure Sensing and Kinetic Modeling of Oxygen-Releasing Endoperoxides for Chemically Driven Micro-ActuationAbhishek Sharma, Vanessa Barth, Henning J Jessen, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2003
Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I studyGiuseppe Frasci, Pasquale Comella, Renato Thomas, et al.
Pageof 69

Showing results (151-160 of 684) with videos related to

Sort By:
Pageof 69
Movement Disorders : Official Journal of the Movement Disorder Society|August 21, 2010
Blood oxygenation level-dependent activation in basal ganglia nuclei relates to specific symptoms in de novo Parkinson's diseaseJaney Prodoehl, Mathew Spraker, Daniel Corcos, et al.
Parkinsonism & Related Disorders|March 8, 2008
Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trialDaniel Truong, Cynthia Comella, Hubert H Fernandez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)F Caponigro, P Comella, F Rivellini, et al.
Oncology|January 26, 2002
A phase I-II study on a gemcitabine-cyclophosphamide-fluorouracil/folinic acid triplet combination in anthracycline- and taxane-refractory breast cancer patientsGiuseppe Frasci, Giuseppe D'Aiuto, Pasquale Comella, et al.
Journal of Neuroscience Methods|October 21, 2000
Combined use of the green and yellow fluorescent proteins and fluorescence-activated cell sorting to select populations of transiently transfected PC12 cellsC Espinet, X Gómez-Arbonés, J Egea, et al.
Revista Clinica Espanola|June 1, 1991
[A study of the tobacco habit in a general hospital]J Serra Batlles, A Comella, J C Casas, et al.
Therapeutics and Clinical Risk Management|May 14, 2009
Role of oxaliplatin in the treatment of colorectal cancerPasquale Comella, Rossana Casaretti, Claudia Sandomenico, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Tetrodotoxin-sensitive ciguatoxin effects on quantal release, synaptic vesicle depletion, and calcium mobilizationJ Molgo, J X Comella, T Shimahara, et al.
ACS Omega|October 13, 2025
Pressure Sensing and Kinetic Modeling of Oxygen-Releasing Endoperoxides for Chemically Driven Micro-ActuationAbhishek Sharma, Vanessa Barth, Henning J Jessen, et al.
Cancer Chemotherapy and Pharmacology|September 27, 2003
Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I studyGiuseppe Frasci, Pasquale Comella, Renato Thomas, et al.
Pageof 69